J&J case signals employee drug price suits to come

By Bloomberg Law
| February 09, 2024

A novel lawsuit from an employee suing J&J for allegedly mismanaging drug benefits appears a harbinger of litigation to come against companies, especially those that rely on PBMs to negotiate pricing and rebates.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...